Search Results - "Damas, N. D."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA by Jedrzejczyk, D. J., Poulsen, L. D., Mohr, M., Damas, N. D., Schoffelen, S., Barghetti, A., Baumgartner, R., Weinert, B. T., Warnecke, T., Gill, R. T.

    Published in Scientific reports (16-07-2022)
    “…CRISPR-Cas12a systems are becoming an attractive genome editing tool for cell engineering due to their broader editing capabilities compared to CRISPR-Cas9…”
    Get full text
    Journal Article
  2. 2

    miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2 by Jansson, M D, Damas, N D, Lees, M, Jacobsen, A, Lund, A H

    Published in Oncogene (09-04-2015)
    “…MicroRNAs (miRNAs) regulate many key cancer-relevant pathways and may themselves possess oncogenic or tumor-suppressor functions. Consequently, miRNA…”
    Get full text
    Journal Article
  3. 3

    CRISPR-Cas12a nucleases function with structurally engineered crRNAs: SynThetic trAcrRNA by Jedrzejczyk, D. J., Poulsen, L. D., Mohr, M., Damas, N. D., Schoffelen, S., Barghetti, A., Baumgartner, R., Weinert, B. T., Warnecke, T., Gill, R. T.

    Published in Scientific reports (16-07-2022)
    “…Abstract CRISPR-Cas12a systems are becoming an attractive genome editing tool for cell engineering due to their broader editing capabilities compared to…”
    Get full text
    Journal Article